Skybiotech Healthcare share news and announcements
BSE: 512036Textiles & ApparelsSmall Cap
Last close ₹116.50down ₹0.50 (0.43%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹117.00.
52-week range of traded prices to 23 Oct 2026
₹113.90Low, 28 Sep 2026₹218.20High, 2 Dec 2025
- Under BSE's graded surveillance, stage 0, on the list for 22 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹22 Cr3,866th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- 2.8
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −14.4%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.91
- Volume, BSEVolume. Shares traded on the last trading day.
- 25
Skybiotech Healthcare routine notices
85 filed, newest first. Page 2 of 2.
Jan 2022
Oct 2021
13 Oct · Routine
Sep 2021
30 Sep · Routine
Jul 2021
Jun 2021
30 Jun · Routine
Apr 2021
Mar 2021
31 Mar · Routine
Jan 2021
4 Jan · Routine
Oct 2020
3 Oct · Routine
Jul 2020
1 Jul · Routine
May 2020
Mar 2020
31 Mar · Routine
Jan 2020
3 Jan · Routine
Oct 2019
Jul 2019
3 Jul · Routine
Apr 2019
12 Apr · Routine
May 2017
Jan 2017
Nov 2016
Aug 2016
May 2016
14 May · Routine
Board Meeting of the Board of Director of the company will he held on 31 May, 2016 Inter alia, to consider Audited Annual accounts of the company ....
Jan 2016
15 Jan · Routine
Meeting of Board of Directors of the Company will be held on February 03, 2016, inter alia, to consider Un - audited results for the 3 months ended ....
Nov 2015
3 Nov · Routine
Board Meeting of the Board of Director of the Company will be held on November 07, 2015 inter- alia, to consider of the following. - To ....
Aug 2015
5 Aug · Routine
Board Meeting of the Board of Directors of the Company will be held on August 14, 2015, inter alia, to consider Un-audited results for the 3 months ....
May 2015
22 May · Routine
Board Meeting of the Board of Directors of the Company will be held May 31, 2015, inter alia, to consider Audited Annual Accounts of the Company ....